• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米药物在前列腺癌治疗中的新兴趋势:观点与潜在应用

Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications.

作者信息

Deshmukh Rohitas, Singh Vaibhav, Harwansh Ranjit K, Agrawal Rutvi, Garg Akash, Singh Sudarshan, Elossaily Gehan M, Ansari Mohd Nazam, Ali Nemat, Prajapati Bhupendra G

机构信息

Institute of Pharmaceutical Research, GLA University, Mathura 281406, India.

Rajiv Academy for Pharmacy, Mathura 281001, India.

出版信息

Pharmaceutics. 2024 Feb 20;16(3):297. doi: 10.3390/pharmaceutics16030297.

DOI:10.3390/pharmaceutics16030297
PMID:38543191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10976144/
Abstract

Prostate cancer is one of the most life-threatening disorders that occur in males. It has now become the third most common disease all over the world, and emerging cases and spiking mortality rates are becoming more challenging day by day. Several approaches have been used to treat prostate cancer, including surgery, radiation therapy, chemotherapy, etc. These are painful and invasive ways of treatment. Primarily, chemotherapy has been associated with numerous drawbacks restricting its further application. The majority of prostate cancers have the potential to become castration-resistant. Prostate cancer cells exhibit resistance to chemotherapy, resistance to radiation, ADT (androgen-deprivation therapy) resistance, and immune stiffness as a result of activating tumor-promoting signaling pathways and developing resistance to various treatment modalities. Nanomedicines such as liposomes, nanoparticles, branched dendrimers, carbon nanotubes, and quantum dots are promising disease management techniques in this context. Nanomedicines can target the drugs to the target site and enhance the drug's action for a prolonged period. They may also increase the solubility and bioavailability of poorly soluble drugs. This review summarizes the current data on nanomedicines for the prevention and treatment of prostate cancer. Thus, nanomedicine is pioneering in disease management.

摘要

前列腺癌是男性中最危及生命的疾病之一。它现已成为全球第三大常见疾病,新发病例和不断攀升的死亡率日益严峻。治疗前列腺癌的方法有多种,包括手术、放射治疗、化疗等。这些都是痛苦且具有侵入性的治疗方式。首先,化疗存在诸多弊端,限制了其进一步应用。大多数前列腺癌有可能发展为去势抵抗性。前列腺癌细胞由于激活促肿瘤信号通路以及对各种治疗方式产生耐药性,从而表现出对化疗、放疗、雄激素剥夺疗法(ADT)的耐药性以及免疫惰性。在此背景下,纳米药物如脂质体、纳米颗粒、分支树枝状大分子、碳纳米管和量子点是很有前景的疾病管理技术。纳米药物可以将药物靶向输送到目标部位,并长时间增强药物作用。它们还可能提高难溶性药物的溶解度和生物利用度。本综述总结了目前关于纳米药物预防和治疗前列腺癌的数据。因此,纳米医学在疾病管理方面正处于领先地位。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/85e343f0076a/pharmaceutics-16-00297-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/e2ec9f9d4c2e/pharmaceutics-16-00297-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/d2cd68cfc15f/pharmaceutics-16-00297-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/19ed0c0026ea/pharmaceutics-16-00297-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/c0dc055a7630/pharmaceutics-16-00297-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/ed62a098ce30/pharmaceutics-16-00297-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/fc93c232ae38/pharmaceutics-16-00297-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/df16bb46cf80/pharmaceutics-16-00297-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/eb883dfe056b/pharmaceutics-16-00297-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/85e343f0076a/pharmaceutics-16-00297-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/e2ec9f9d4c2e/pharmaceutics-16-00297-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/d2cd68cfc15f/pharmaceutics-16-00297-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/19ed0c0026ea/pharmaceutics-16-00297-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/c0dc055a7630/pharmaceutics-16-00297-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/ed62a098ce30/pharmaceutics-16-00297-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/fc93c232ae38/pharmaceutics-16-00297-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/df16bb46cf80/pharmaceutics-16-00297-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/eb883dfe056b/pharmaceutics-16-00297-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c5f/10976144/85e343f0076a/pharmaceutics-16-00297-g009.jpg

相似文献

1
Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications.纳米药物在前列腺癌治疗中的新兴趋势:观点与潜在应用
Pharmaceutics. 2024 Feb 20;16(3):297. doi: 10.3390/pharmaceutics16030297.
2
Nanomedicines in diagnosis and treatment of prostate cancers: an updated review.纳米药物在前列腺癌诊断与治疗中的应用:最新综述
Front Bioeng Biotechnol. 2024 Aug 21;12:1444201. doi: 10.3389/fbioe.2024.1444201. eCollection 2024.
3
Current progress of nanomedicine for prostate cancer diagnosis and treatment.纳米医学在前列腺癌诊断与治疗中的当前进展
Biomed Pharmacother. 2022 Nov;155:113714. doi: 10.1016/j.biopha.2022.113714. Epub 2022 Sep 20.
4
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.EAU 前列腺癌指南。第二部分:晚期、复发性和去势抵抗性前列腺癌的治疗。
Eur Urol. 2014 Feb;65(2):467-79. doi: 10.1016/j.eururo.2013.11.002. Epub 2013 Nov 12.
5
Emerging frontiers in nanomedicine targeted therapy for prostate cancer.纳米医学靶向治疗前列腺癌的新兴前沿。
Cancer Treat Res Commun. 2023;37:100778. doi: 10.1016/j.ctarc.2023.100778. Epub 2023 Nov 14.
6
Envisioning the Future of Nanomedicines in Management and Treatment of Neurological Disorders.展望纳米药物在神经疾病管理与治疗中的未来。
Comb Chem High Throughput Screen. 2021;24(10):1544-1556. doi: 10.2174/1386207323666201217151132.
7
Targeted nanomedicine modalities for prostate cancer treatment.用于前列腺癌治疗的靶向纳米医学模式。
Drug Resist Updat. 2021 May;56:100762. doi: 10.1016/j.drup.2021.100762. Epub 2021 Mar 19.
8
Nanomedicines as cancer therapeutics: current status.纳米药物作为癌症治疗剂:现状。
Curr Cancer Drug Targets. 2013 May;13(4):362-78. doi: 10.2174/1568009611313040002.
9
Current management of advanced and castration resistant prostate cancer.晚期及去势抵抗性前列腺癌的当前管理
Can J Urol. 2014 Apr;21(2 Supp 1):1-6.
10
Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.肥胖与雄激素剥夺治疗后行根治性前列腺切除术的男性的去势抵抗性疾病和转移相关:来自 SEARCH 数据库的结果。
BJU Int. 2012 Aug;110(4):492-8. doi: 10.1111/j.1464-410X.2011.10754.x. Epub 2011 Nov 17.

引用本文的文献

1
ERLNs augment simultaneous delivery of GFSV into PC-3 cells: Influence of drug combination on SDH, GPX-4, 5α-RD, and cytotoxicity.内质网应激相关蛋白增强吉西他滨向PC-3细胞的同步递送:药物组合对琥珀酸脱氢酶、谷胱甘肽过氧化物酶4、5α-还原酶及细胞毒性的影响。
Oncol Res. 2025 Mar 19;33(4):919-935. doi: 10.32604/or.2024.054537. eCollection 2025.
2
Precision Therapy for Prostate Cancer: Advancements in Polymeric Nanocarrier Systems.前列腺癌的精准治疗:聚合物纳米载体系统的进展
Anticancer Agents Med Chem. 2025 Jan 30. doi: 10.2174/0118715206360906241223120425.
3
Demystifying the management of cancer through smart nano-biomedicine via regulation of reactive oxygen species.

本文引用的文献

1
Phosphatidylcholine (PCL) fortified nano-phytopharmaceuticals for improvement of therapeutic efficacy.用于提高治疗效果的磷脂酰胆碱(PCL)强化纳米植物药。
EXCLI J. 2023 Aug 18;22:880-903. doi: 10.17179/excli2023-6345. eCollection 2023.
2
Current Trends in the Biomarker'sDiscovery for the Treatment and Management of Colorectal Cancer: A ComprehensiveReview.结直肠癌治疗与管理中生物标志物发现的当前趋势:全面综述
Curr Med Chem. 2024 Jan 31. doi: 10.2174/0109298673274455231219044728.
3
Transferosomes stabilized hydrogel incorporated rhodomyrtone-rich extract from Rhodomyrtus tomentosa leaf fortified with phosphatidylcholine for the management of skin and soft-tissue infections.
通过智能纳米生物医学调控活性氧来揭开癌症治疗的神秘面纱。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):497-532. doi: 10.1007/s00210-024-03469-x. Epub 2024 Oct 31.
4
Recent Advancements in the Diagnosis and Management of Cancer Using Biomaterials-Fabricated Nanofibers: A Review.利用生物材料制备的纳米纤维进行癌症诊断与治疗的最新进展:综述
Curr Med Chem. 2024 May 9. doi: 10.2174/0109298673293056240502113235.
转铁脂质体稳定化水凝胶包裹毛稔叶富含玫红菌素的提取物,并添加磷脂酰胆碱,用于治疗皮肤和软组织感染。
Biotechnol Lett. 2024 Feb;46(1):127-142. doi: 10.1007/s10529-023-03452-1. Epub 2023 Dec 27.
4
Facile green synthesis and characterization of bark phenolic-selenium nanogel: a biocompatible and green nano-biomaterial for multifaceted biological applications.树皮酚类-硒纳米凝胶的简便绿色合成与表征:一种用于多方面生物应用的生物相容性绿色纳米生物材料。
Front Chem. 2023 Sep 22;11:1273360. doi: 10.3389/fchem.2023.1273360. eCollection 2023.
5
Survivin-targeted nanomedicine for increased potency of abiraterone and enzalutamide against prostate cancer.针对存活素的纳米医学提高阿比特龙和恩杂鲁胺治疗前列腺癌的效力。
Eur J Pharm Biopharm. 2023 Nov;192:88-111. doi: 10.1016/j.ejpb.2023.10.005. Epub 2023 Oct 4.
6
Nanoparticles drug delivery for 5-aminolevulinic acid (5-ALA) in photodynamic therapy (PDT) for multiple cancer treatment: a critical review on biosynthesis, detection, and therapeutic applications.用于光动力疗法(PDT)中 5-氨基酮戊酸(5-ALA)的纳米颗粒药物递送治疗多种癌症:生物合成、检测和治疗应用的批判性综述。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17607-17634. doi: 10.1007/s00432-023-05429-z. Epub 2023 Sep 30.
7
Integrin-targeting disulfide-crosslinked micellar docetaxel eradicates lung and prostate cancer patient-derived xenografts.整合素靶向二硫键交联胶束多西紫杉醇根除肺癌和前列腺癌患者来源异种移植物。
Acta Biomater. 2023 Oct 15;170:228-239. doi: 10.1016/j.actbio.2023.08.043. Epub 2023 Aug 25.
8
Poly-l-glutamic acid modification modulates the bio-nano interface of a therapeutic anti-IGF-1R antibody in prostate cancer.聚-L-谷氨酸修饰调节治疗性抗IGF-1R抗体在前列腺癌中的生物纳米界面。
Biomaterials. 2023 Oct;301:122280. doi: 10.1016/j.biomaterials.2023.122280. Epub 2023 Aug 14.
9
Tumor acidity-activatable macromolecule autophagy inhibitor and immune checkpoint blockade for robust treatment of prostate cancer.肿瘤酸性激活大分子自噬抑制剂和免疫检查点阻断联合治疗前列腺癌的研究进展
Acta Biomater. 2023 Sep 15;168:593-605. doi: 10.1016/j.actbio.2023.07.018. Epub 2023 Jul 18.
10
Nanotechnology-Aided Advancement in Combating the Cancer Metastasis.纳米技术助力对抗癌症转移的进展
Pharmaceuticals (Basel). 2023 Jun 19;16(6):899. doi: 10.3390/ph16060899.